UBS Group’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
|
|||||
|
2025
Q1 | $166K | Sell |
|
|||||
|
2024
Q4 | $416K | Buy |
|
|||||
|
2024
Q3 | $267K | Buy |
|
|||||
|
2024
Q2 | $138K | Sell |
|
|||||
|
2024
Q1 | $227K | Buy |
|
|||||
|
2023
Q4 | $396K | Sell |
|
|||||
|
2023
Q3 | $882K | Buy |
|
|||||
|
2023
Q2 | $612K | Buy |
|
|||||
|
2023
Q1 | $428K | Sell |
|
|||||
|
2022
Q4 | $2.47M | Buy |
|
|||||
|
2022
Q3 | $1.43M | Sell |
|
|||||
|
2022
Q2 | $4.99M | Buy |
|
|||||
|
2022
Q1 | $3.94M | Buy |
|
|||||
|
2021
Q4 | $2.98M | Buy |
|
|||||
|
2021
Q3 | $2.86M | Buy |
|
|||||
|
2021
Q2 | $37K | Sell |
|
|||||
|
2021
Q1 | $426K | Buy |
|
|||||
|
2020
Q4 | $155K | Buy |
|
|||||
|
2020
Q3 | $20K | Buy |
|